Pharma Journalist - Page 100 of 946 -

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sandoz and Henlius Expand Global Biosimilar Collaboration

Ethris and Lonza Partner on Spray-Dried mRNA Vaccines for Respiratory Diseases

UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease

Sangamo and Lilly Partner on Capsid License for CNS Genomic Medicines

Boehringer Ingelheim Expands ADC Portfolio with New R&D Center in Basel

Neurona Therapeutics Raises $102M for NRTX-1001 Phase 3 Trial

Rilzabrutinib Receives Orphan Drug Designation for Two Rare Diseases

Novartis Gets FDA Accelerated Approval for Vanrafia in IgAN

Flagship Pioneering and Pfizer Partner to Develop Selective Inhibitors for Autoimmune Diseases

Astellas Partners with Japanese Cancer Foundation to Boost Oncology Research

EU Approves Pfizer’s RSV Vaccine ABRYSVO for Adults 18-59